Publishing News, newswire

Publishing News & Press Release Distribution Services

Submit Press Release | About Us

Home | Publishing News | News Releases | Press Release Distribution | Free Trade Magazines
Unlimited Press Release Distribution
Press release distribution service

Media List
AllThings Digital
Digital Book World
Editor & Publisher
Good E-Reader
Folio
GalleyCat
O'Reilly Media
Publishing News Brazil
Publishing Trendsetter
Publishers Weekly
Salon
Self Publishing
The Digital Reader
TeleRead

Free Publications


Yes! Please subscribe me!

 
Enter email address above.

Publishing News and Press Releases

Peptide Therapeutics Market Size Estimated to Reach $48.2 Billion by 2026

(Publishing-NewsWire.com, September 02, 2021 ) Peptide Therapeutics Market size is estimated to reach $48.2 billion by 2026, growing at a CAGR of 9.4% during the forecast period 2021-2026. Peptides are short chains of amino acids that perform many roles within the cell, such as anti-infectives and signaling. These therapeutics have the ability to treat various conditions from peptide replacement to antivirals. Peptide therapeutics are increasingly being adopted across the world owing to the rise in the prevalence of gastrointestinal disorders, cancer, and metabolic disorders.



The rise in the prescription of peptide therapeutics for the treatment of cancer, increasing adoption of generic peptides for various infectious diseases owing to its cost-effectiveness, rise in the adoption of peptides as medical diagnostic devices, and growing investment by the key players to develop advanced peptide therapeutics are the factors that are set to drive the growth of the Peptide Therapeutics Market for the period 2021-2026.



Peptide Therapeutics Market Segment Analysis-By Type



The Peptide Therapeutics Market based on the Type can be further segmented into Generic and Branded. The Branded segment held the largest share in 2020 owing to the factors such as the rise in the number of infectious diseases and the increase in the demand for original products in developed nations. The growing investments by the key players in research and development activities for the development of novel drugs is driving the growth of the Peptide Therapeutics Market.



The Generic segment is estimated to be the fastest growing segment with a CAGR of 10.6% over the period 2021-2026. This growth is owing to the factors such as the growing expenditure on healthcare by the governments, increase in the demand for generic peptides, and the rise in the product launches by key players.



Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=17367



Report Price: $ 4500 (Single User License)



Peptide Therapeutics Market Segment Analysis-By Application



The Peptide Therapeutics Market based on the Application can be further segmented into Gastrointestinal Disorders, Cancer, Metabolic Disorders, Neurological Disorders, and Others. The Cancer segment held the largest share in 2020 owing to the factors such as increase in the prescription of peptide therapeutics for the treatment of cancer and rise in the investment by the key players to develop advanced peptide therapeutics for cancer treatment.



The rise in awareness among healthcare professionals about the adverse effects of radiation therapy is driving the growth of the Peptide Therapeutics Market. The Metabolic Disorders segment is estimated to be the fastest growing segment with a CAGR of 11.2% over the period 2021-2026. This growth is owing to the factors such as the growing demand for generic peptides for the treatment of metabolic disorders, the rise in the adoption of medical diagnostic devices, and increase in the base of the geriatric population susceptible to metabolic disorders in developed nations.



Peptide Therapeutics Market Segment Analysis-By Geography



North America held the largest share with 31% of the overall market in 2020. The growth in this segment is owing to the factors such as the rise in the adoption of peptides as medical diagnostic devices and the increase in the prescription of peptide therapeutics for the treatment of cancer. The rise in the product launches by key players is driving the growth of the Peptide Therapeutics Market. Asia-Pacific segment is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as the rise in the adoption of generic peptides for various infectious diseases and growing investment by the key players to develop advanced peptide therapeutics.



Inquiry Before Buying @ https://www.industryarc.com/reports/request-quote?id=17367



Peptide Therapeutics Market Drivers



Increase in the Prevalence of Metabolic Disorders



Owing of their cost-effectiveness, the market for generic peptides has increased as the prevalence of metabolic disorders has increased. The main players are also concentrating on developing advanced peptide therapeutics as a result of the rise in the number of geriatrics in developed countries who are susceptible to metabolic disorders, which is fueling the growth of the Peptide Therapeutics Market.

Rise in the Adoption of Innovative Platforms to Develop Next-Generation Peptide Therapeutics

Biopharmaceutical companies are increasingly focusing on innovative platforms to develop next-generation peptide treatments for immuno-inflammatory diseases. For instance, companies such as Novo Nordisk A/S and Almirall S.A. are investing in PolyXen technology, which is a patent-protected platform technology that develops first-in-class peptide treatments for immuno-inflammatory diseases, which is one of the major factors driving the growth of the Peptide Therapeutics Market.



Peptide Therapeutics Market Challenges



Stringent Government Regulations



The key players in the market are collaborating with other players to carry out various research and development activities for launching advanced generic peptides for the treatment of various disorders. However, peptide therapeutics require a better regulatory framework, which is one of the major factors that is estimated to reduce the growth of the Peptide Therapeutics Market.



Peptide Therapeutics Market Competitive Landscape:



Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Peptide Therapeutics Market. Key companies of this market are Eli Lilly and Company, Pfizer Inc, Bachem Holding AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical, Sanofi, Bristol-Myers Squibb (BMS), GlaxoSmithKline, AstraZeneca PLC, and Novo Nordisk A/S among others.



Acquisitions/Partnerships:



In March 2021, Takeda Pharmaceutical Company Limited has entered into a partnership with Anima Biotech to discover and develop a new class of peptides and protein drugs for genetically-defined neurological diseases.



In December 2020, Eli Lilly has acquired Prevail Therapeutics for an aggregate value of up to $1.04Bn to advance its research and development capabilities on peptide-based therapies with the support of the company portfolio of preclinical neuroscience assets.



Key Takeaways



Geographically, North America Peptide Therapeutics Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the rise in the adoption of peptides as medical diagnostic devices.



The cancer category is being driven by an increase in the prescription of peptide therapeutics for cancer care in developing countries. Government regulations, on the other hand, are said to be one of the major factors limiting the growth of the Peptide Therapeutics Market.



Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Peptide Therapeutics Market report.



Related Reports:



A. Peptide Synthesis Market

https://www.industryarc.com/Research/Peptide-Synthesis-Market-Research-505605



B. Peptide And Anticoagulant Drugs Market

https://www.industryarc.com/Research/Peptide-And-Anticoagulant-Drugs-Market-Research-505689



For more Lifesciences and Healthcare Market reports, please click here



About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

IndustryARC

Venkat Reddy

(+1) 970-236-3677

venkat@industryarc.com

Source: EmailWire.Com

Publishing News by Sector
  • Management
  • Online Publishing
  • People
  • Manufacturing
  • Production
  • Syndication
  • Technology
  • Publihing Resource Center
    We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:

    Governing
    Point of Beginning
    Overall Labor Effectiveness (OLE) Achieving a Highly Effective Workforce

    No credit cards, coupons, or promo codes required. Try it today!

    Press release service

    Publishing-Newswire.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

    For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com.


    GroupWeb Media Network
    AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
    | InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |

    Publishing-Newswire.Com - Newswire and Press Release service of GroupWeb Media LLC